Zurich
-
Massachusetts-based Biofourmis to acquire Zurich wearable company
Biofourmis’s CEO boldly declared the company will become a unicorn and this acquisition is expected to give the startup access to more raw data as it expands its analytics platforms and brings Biovotion’s Everion wearable armband inhouse.
-
The first “cyborg Olympics” will happen this year – featuring exoskeleton and powered wheelchair competitions
Cybathon 2016 will be a competition that takes place this October in Zurich – it’s being referred to as the cyborg Olympics. Among some of the events, competitors will be using things like advanced exoskeletons and powered wheelchairs.
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Devices & Diagnostics, BioPharma
Xeltis has developed the first bioabsorbable heart valve
Complications that come with having foreign material in the body, like increased inflammation and potential revision surgery, could be avoided with bioabsorbable technology.
-
Devices & Diagnostics, Startups
Starting your medical device startup in Europe? Consider 4 tips from CEOs who’ve been there, done that
What with the medical device tax and regulatory hurdles, there is a lot of medical […]
-
Devices & Diagnostics, Startups
Shock absorbers for the human body? Implant could help active patients avoid total knee replacements longer
Think shock absorbers for the human body. Moximed could help active and young patients who […]
-
Novartis says Alcon’s eye drug Jetrea gets EU approval
ZURICH (Reuters) – Novartis said its Alcon unit got a green light from the European Commission for Jetrea, a drug that treats an eye condition that can lead to blindness.
Jetrea is the first eye drug to treat vitreomacular traction (VMT) associated wit…